Samsung Electronics Co., Ltd. et al. v. SiOnyx, LLC

IPR2025-00064

The PTAB denied Samsung Electronics' IPR petition against SiOnyx, LLC due to significant overlap with a parallel district court case. The Board found that the proximity of the trial date and overlapping issues outweighed the Petitioner’s strong merits arguments regarding anticipation and obviousness in semiconductor technology.

Jurisdiction
US PTAB
Case Number
IPR2025-00064
Judge(s)
GEORGIANNA W. BRADEN, MONICA S. ULLAGADDI, BRIAN D. RANGE
Decision Date
22 November 2024

Detailed Summary

Samsung Electronics Co., Ltd. (Petitioner) sought to invalidate claims of U.S. Patent No. 10347682 held by SiOnyx, LLC (Patent Owner) via an IPR petition. The Board ultimately denied institution under Fintiv discretion. While the Petitioner presented strong arguments on the merits—including expert evidence showing prior art like Haddad138 teaches claim limitations and that Park/Baggenstoss renders claim 24 obvious—the Board determined that the significant overlap in issues, parties, and the proximity of a parallel district court trial date warranted discretionary denial. The decision emphasizes the weight given to docket management concerns when evaluating IPR petitions alongside active litigation.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Samsung Electronics Co., Ltd. et al. vs SiOnyx, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentIPR2025-01383

Ford Motor CompanyvsAutoConnect Holdings LLC

AutoConnect’s counsel urges the PTAB to deny Ford’s IPR petition, citing Ford’s contradictory indefiniteness arguments and settled‑expectations grounds. The brief references Board guidance that disallows “having it both ways.”

patentIPR2025-01191

Guangzho EKO Trading Development Co., Ltd. (aka EKO Development Ltd.) et al.vsNine Stars Group (U.S.A.) Inc.

The PTAB instituted IPR proceedings against Nine Stars Group (U.S.A.) Inc., finding a reasonable likelihood that claims 1-24 of patent 10822165 are anticipated or obvious over the prior art reference Wang. The Board accepted Petitioner's arguments regarding functional equivalency, particularly concerning 'automatic driving arrangement' and components like the servo motor.

patentIPR2025-00486

Advanced Micro Devices, Inc. et al.vsXtreamEdge, Inc. et al.

Advanced Micro Devices (AMD) and Pensando Systems successfully convinced the PTAB that XtreamEdge's network testing claims are likely obvious under 35 U.S.C. § 103. The Board issued an institution decision, moving the dispute toward trial on grounds of obviousness over multiple prior art references.

patentIPR2025-00156

Imperative Care, Inc.vsInari Medical, Inc.

The PTAB instituted an inter partes review of Inari Medical’s 11,554,005 B2 embolism‑treatment patent after finding Imperative Care likely to prevail on at least one claim, primarily on obviousness grounds involving hemostasis valve features.

patentIPR2024-00787

Hulu LLC et al.vs--

Hulu and Capital One filed an unopposed motion to terminate IPR2024-00787 after settling their dispute with patent owner Implicit, LLC. The Board was asked to end the proceeding, which had not yet been instituted.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call